Veeva Systems announced that it has acquired Copli, a company known for developing agentic medical, legal, and regulatory solutions for the life sciences industry.
Following the acquisition, Copli is now available as Veeva Falcon MLR, an agentic MLR solution designed to accelerate content review and reduce manual review work across life sciences commercial and medical content operations.
Veeva said Falcon MLR has the potential to eliminate 70% or more of manual MLR labor within five years. The solution brings agentic automation to marketing teams, MLR groups, and agencies by conducting rigorous reviews of promotional and medical materials.
Veeva Falcon MLR performs compliance checks against approved labels and local regulations. By automating routine review tasks, the platform is designed to reduce manual effort, shorten review cycles, and allow reviewers to focus on higher-value strategic work.
The launch of Veeva Falcon MLR expands Veeva’s commercial content capabilities and integrates agentic review automation with Veeva PromoMats. The company said the product is now available to customers.
Veeva Systems delivers industry cloud software, AI, data, and consulting for the life sciences sector. The company serves more than 1,500 customers, including major pharmaceutical companies and emerging biotechs.
KEY QUOTES:
“Our breakthrough with agentic MLR marks a fundamental shift in commercial and medical content review and approval.”
“As part of Veeva, we can scale our vision for MLR transformation. Veeva Falcon MLR brings compliance at speed to the industry with intelligent agents that work seamlessly with Veeva PromoMats.”
Jacob Scheel-Bech, CEO of Copli
“The MLR process has long been a significant bottleneck in getting critical information to patients and doctors.”
“With Veeva Falcon MLR, our customers can speed up the entire review cycle, automating routine labor so reviewers can become strategic advisors.”
Emma Hyland, Vice President of Veeva Commercial Content
